Article
TP53 mutation prevalence in normal airway epithelium as a biomarker for lung cancer risk
2023-05-30
Abstract excerpt
<h4>Background: </h4> There is a need for biomarkers that improve accuracy compared with current demographic risk indices to detect individuals at the highest lung cancer risk. Improved risk determination will enable more effective lung cancer screening and better stratification of lung nodules into high or low-risk category. We previously reported discovery of a biomarker for lung cancer risk characterized by inc...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- c14adced-0603-5aa2-a953-1db237e8457e
- DOI
- 10.21203/rs.3.rs-2957987/v1
